
5.97 Delayed Data As of Jan 26 | ![]() Today’s Change | 3.17 Today|||52-Week Range 10.29 | +16.37% Year-to-Date |
AlloVir, Inc. (ALVR) Upgraded to Buy: Here's What You Should Know Jan 25 / Zacks.com - Paid Partner Content | Are Medical Stocks Lagging Adicet Bio (ACET) This Year? Jan 25 / Zacks.com - Paid Partner Content |
How Much Upside is Left in AlloVir, Inc. (ALVR)? Wall Street Analysts Think 355.8% Jan 25 / Zacks.com - Paid Partner Content |
Previous close | 5.59 |
Today’s open | 5.70 |
Day’s range | 5.64 - 6.05 |
Volume | 325,612 |
Average volume (3 months) | 289,005 |
Market cap | $489.1M |
Earnings growth (last year) | -5.57% |
Earnings growth (this year) | +16.92% |
Earnings growth (next 5 years) | -- |
Revenue growth (last year) | -- |
P/E ratio | NM |
Price/Sales | -- |
Price/Book | 1.48 |
No competitors data available. |
Next reporting date | February 9, 2023 |
EPS forecast (this quarter) | -$0.51 |
Annual revenue (last year) | $0.00 |
Annual profit (last year) | -$172.0M |
Net profit margin | -- |
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters --, -- |